Socioenvironmental determinants of polypharmacy in mental health disorders: a systematic review
Gobezie Temesgen Tegegne, Hossein Tabatabaei-Jafari, Theophile Niyonsenga, Saba Ghiasvand, Yassamin Bagheri, Nasser Bagheri · 2026
Read Socioenvironmental determinants of polypharmacy in mental health disorders: a systematic review by Gobezie Temesgen Tegegne, Hossein Tabatabaei-Jafari, Theophile Niyonsenga, Saba Ghiasvand, Yassamin Bagheri, Nasser Bagheri (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13321598.txt.
Description
Gobezie Tegegne and co-authors offer a 2026 review on social and environmental factors in polypharmacy for mental health. Polypharmacy means taking many drugs at once, here for the mind and brain. How place, income, and family life shape that pattern was unknown. The team searched five sources plus web and reference lists for studies on the topic.
In all, 57 studies gave 65 findings. Median rates were about 30 percent for broad drug polypharmacy and 28 percent for antipsychotic polypharmacy. Rates ran higher in hospital patients and in schizophrenia care. A few social factors tied clearly to polypharmacy, among them income, family strain, and deprivation. The authors call for deeper work on factors that can be changed.
Catalog record
| CREATOR | Gobezie Temesgen Tegegne, Hossein Tabatabaei-Jafari, Theophile Niyonsenga, Saba Ghiasvand, Yassamin Bagheri, Nasser Bagheri |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 31 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |